FH

Frank Stephen Hodi

Highly Cited Researcher 2025

Dana-Farber Cancer Institute

Frank Stephen Hodi is a medical oncologist and researcher at Dana-Farber Cancer Institute whose work focuses on cancer immunotherapy, particularly immune checkpoint inhibitors for melanoma and other cancers. He has contributed to the clinical development of immunotherapy approaches that harness the immune system against tumors.

Field
Medicine · Oncology
Clarivate categories
Clinical Medicine; Immunology
Affiliation
Dana-Farber Cancer Institute, United States